Strategic Planning
HIMSS24
Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.
Harvard research associate Brian Spisak discusses how a "leadership-first, tech-last" approach can prevent organisations from deploying ticking time bombs.
Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.
Rachael Charbonneau, American Heart Association senior program development manager of health science, discusses the Center for Health Technology and Innovation and its training program aimed at improving digital health literacy.
HIMSS24
Lyle McMillin, principal product manager at Hyland, explains how a vendor partner focused on following interoperability standards can help providers work with partner organizations to improve their data exchange.
Ashok Chennuru, global chief data and insights officer at Elevance Health, and Oron Afek, CEO of Vim, discuss scaling artificial intelligence to accelerate workflows, enhance patient care and unlock personalized medicine.
HIMSS24
Joe O'Brien, head of sales, digital health at LG Electronics, says the company plans to use AI tools in smart hospital rooms to provide better patient experiences by supplementing, not replacing, in-person care.
Adjunct faculty at Stanford Health Care and CMO and cofounder of Atropos Health, Saurabh Gombar, discusses a study analyzing five LLMs and their accuracy in producing actionable and reliable evidence for healthcare-related questions.
HIMSS24
Marilee Benson, president and cofounder of Zen Healthcare IT, talks about how the company's interoperability product enables AI tools to access healthcare data needed for use cases such as identifying patients for clinical trials.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.